ProPhase (PRPH): Market Capitalization-to-Revenue Ratio

Symbol and logo of brand ProPhase Labs Inc (PRPH)

The development of ProPhase Labs, Inc. (PRPH) relies on scaling genetic research and maintaining resilience to market cycles through innovation. The company's historical P/S ratio visualizes the balance between the defensive value margin and sales growth rates, while the 0.20 metric confirms the current valuation level. High confidence in diagnostic quality solidifies its status as a dynamic player in the healthcare sector.

PRPH ProPhase Labs Corp Price-to-Revenue Ratio (07/04/2022 - 12/31/2025)

Analytical breakdowns for ProPhase (PRPH)

- share price and expert price forecast:
Quote Chart prophaselabs.com|PRPH - Price Target Chart
- stock exchange capitalization data:
Market Value ProPhase|PRPH - Total Company Value
- book capitalization indicators:
Net Asset Value per Share ProPhase Labs|PRPH - Company Book Value|Market Capitalization to Net Assets prophaselabs.com|PRPH - Company Total Assets
- issuer credit burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio ProPhase Labs, Inc.|PRPH - Long-Term Debt to Capital|Short-Term Debt to Capital ProPhase Labs Corp|PRPH - Company Debts|Debts to Net Assets ProPhase|PRPH - Company Long-Term Debts|Short-Term Debt ProPhase Labs|Intermediate Coverage Ratio prophaselabs.com
- earnings and multiples data:
PRPH - Company Net Income|Expected Profit ProPhase Labs, Inc.|PRPH - P/E Multiple|Forward P/E Multiple ProPhase Labs Inc|PRPH - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ProPhase|PRPH - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters ProPhase Labs|PRPH - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months prophaselabs.com|PRPH - Earnings growth in current year|Consensus forecast of earnings per share growth for next year ProPhase Labs, Inc.
- total revenue and sales volume data:
PRPH - Company Revenue|Company Revenue Forecast prophaselabs.com|PRPH - P/S Multiple|Forward Price-to-Revenue Multiple ProPhase
Fundamental company analysis:PRPH, prophaselabs.com
Finished products of ProPhase

The P/S multiple for ProPhase Labs, Inc. (PRPH) is calculated by dividing its market capitalization by its annual revenue. This ratio determines the cost of one dollar of sales, signaling whether the asset is overvalued or undervalued. For a high-tech genomic sequencing ecosystem with high customer retention costs, this metric reflects market confidence in the scalability of AI platforms. The price action of the P/S multiple allows for an assessment of the monetization efficiency of diagnostic services.

Competing companies

A: Price-to-Sales Ratio|Price-to-Revenue Ratio Quest Diagnostics Incorporated DGX|Market Capitalization-to-Revenue Ratio ILMN|EXAS - Price-to-Revenue Ratio|Price to Sales Revvity Corp|Bio-Rad Laboratories (BIO) - Price-to-Revenue Ratio|Price-to-Sales Ratio NNNN (anbio.com)|SHC (Sotera Health) - P/S Multiple|QDEL: Market Capitalization-to-Revenue Ratio|P/S Multiple OPK|P/S Multiple CareDx Health (CDNA)|Price-to-Revenue Ratio Maravai LifeSciences MRVI|Price-to-Revenue Coefficient fulgentgenetics.com (FLGT)|Standard BioTools - P/S Multiple|Price to Sales Cytek Biosciences Inc|OSUR (OraSure Technologies Inc) - Market Cap to Revenue|Exagen - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio MDxHealth SA|Price-to-Revenue Ratio LUCD|P/S Multiple PRE|P/S Multiple imdxinc.com (IMDX)|P/S Multiple TRIB (Trinity Biotech)|Ainos Corporation - Price-to-Revenue Ratio|CODX - Price-to-Revenue Ratio|Price-to-Revenue Coefficient heartsciences.com HSCS|BMRA (Biomerica) - Market Cap to Revenue|Cardio Diagnostics Holdings - Market Capitalization-to-Revenue Ratio|ONCO (Onconetix Corp) - P/S Multiple|Virax Biolabs Corp (VRAX) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Bluejay Diagnostics (BJDX)|aspirawh.com - Market Cap to Revenue Ratio|P/S Multiple AXDX (Accelerate Diagnostics, Inc.)|CNTG - Market Cap to Revenue|ENZ: Market Cap to Revenue|Price-to-Revenue Coefficient Fresh2 Group Limited FRES|gtglabs.com (GENE) - Price-to-Revenue Ratio|Price-to-Sales Ratio ME (23andme.com)|Price-to-Revenue Ratio Psychemedics Corporation